{"id":"W4322762721","doi":"10.1016/s2468-1253(23)00003-1","title":"The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission","year":2023,"lang":"en","type":"review","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":191,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; University of Toronto; University of Calgary; Mount Sinai Hospital; University of Manitoba","funders":"Janssen Canada; Takeda Canada; Eli Lilly Japan; Pfizer Canada; Amgen Canada; Pfizer Japan; Genentech; AbbVie Canada; Sandoz Canada; Grifols; Mitsubishi Tanabe Pharma Corporation; Otsuka Pharmaceutical; Samsung; Bristol-Myers Squibb; Royal Adelaide Hospital; Novo Nordisk; Celltrion; Kissei; Mylan; Dr. Falk Pharma; Health Foundation Limburg; Shire; Eli Lilly and Company; Allergan; AstraZeneca; Celltrion Healthcare; EA Pharma Co., Ltd.; Leona M. and Harry B. Helmsley Charitable Trust; Celgene; Pfizer; Biogen; Norgine; Boehringer Ingelheim Japan; Gilead Sciences; Tillotts Pharma; Amgen; Vifor Pharma; Kyorin Pharmaceutical","keywords":"Medicine; Hepatology; Health care; Inflammatory bowel disease; Ulcerative colitis; Productivity; Disease; Intensive care medicine; Commission; Business; Internal medicine; Economic growth; Finance","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001977092,0.001170237,0.001998668,0.001482941,0.000515316,0.002034661,0.001387508,0.004065426,0.01022918],"category_scores_gemma":[0.004632738,0.0003381764,0.0009184985,0.002102937,0.001008478,0.00275255,0.001391589,0.005536805,0.003583691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002620403,"about_ca_system_score_gemma":0.004618139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004768567,"about_ca_topic_score_gemma":0.008614843,"domain_scores_codex":[0.9993501,0.0001673526,0.00005221067,0.00005232178,0.0002765055,0.000101503],"domain_scores_gemma":[0.9971262,0.001455185,0.0002421758,0.00005739057,0.0007866863,0.0003324967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001360625,0.00002296738,0.00007660023,0.00574584,0.0001017719,0.000122219,0.00003140533,0.0002132542,0.0001789034,0.01056245,0.6062376,0.3765709],"study_design_scores_gemma":[0.00005279919,0.00003759631,0.0005860999,0.00669411,0.0000722971,0.0002569016,0.00006767568,0.00005351223,0.00003280228,0.004011585,0.9881166,0.00001794818],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003289825,0.9822449,0.00003051733,0.01251035,0.004050311,0.00000196747,0.00003144818,0.000007571585,0.001090007],"genre_scores_gemma":[0.0007386048,0.9869907,0.00008018837,0.007655226,0.003432366,0.000007055415,0.00004782808,0.000004423743,0.001043541],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01022918,"threshold_uncertainty_score":0.03421998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02296805245771017,"score_gpt":0.2955426296688889,"score_spread":0.2725745772111787,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}